Earnings Call · Q3 FY2022·2022-11-04

Q3 22EPS -2.17%·Rev n/aQ2 22EPS -39.39%·Rev n/aQ1 22EPS +16.33%·Rev n/aQ4 21EPS -10.87%·Rev n/a⚠ consensus missing

Autolus Therapeutics plc AUTL

Olivia Manser — Director of Investor Relations

Christian Itin — Chief Executive Officer

Lucinda Crabtree — Chief Financial Officer

−11.2%1d on move date−12.6% vs SPY3d−22.0%5d−16.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AUTL calls or request research access.

More AUTL calls Browse calls Request research access